Get the Stockscreener App
24.17
0.55%
0.1328
Amplify Weight Loss Drug Treatment Etf stock is traded at $24.17, with a volume of 816.
It is up +0.55% in the last 24 hours and down -6.22% over the past month.
See More
Previous Close:
$24.03
Open:
$23.9
24h Volume:
816
Relative Volume:
0.87
Market Cap:
$5.56M
Revenue:
Net Income/Loss:
P/E Ratio:
-
EPS:
-
Net Cash Flow:
1W Performance:
-2.18%
1M Performance:
-6.22%
6M Performance:
-2.67%
1Y Performance:
+2.75%
1-Day Range:
$23.50
$24.17
1-Week Range:
$23.50
$24.52
52-Week Range:
$22.89
$27.94
Amplify Weight Loss Drug Treatment Etf Stock (THNR) Company Profile
Name
Amplify Weight Loss Drug Treatment Etf
Sector
Industry
Phone
-
Address
-
Compare THNR vs VOO, IVV, SPY, VTI, QQQ
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
THNR
Amplify Weight Loss Drug Treatment Etf
|
24.17 | 5.56M | 0 | 0 | 0 | 0.00 |
VOO
Vanguard S P 500 Etf
|
707.43 | 1.04T | 0 | 0 | 0 | 0.00 |
IVV
Ishares Core S P 500 Etf
|
773.09 | 887.12B | 0 | 0 | 0 | 0.00 |
SPY
Spdr S P 500 Etf Trust
|
769.60 | 812.80B | 0 | 0 | 0 | 0.00 |
VTI
Vanguard Total Stock Market Etf
|
376.88 | 694.13B | 0 | 0 | 0 | 0.00 |
QQQ
Invesco Qqq Trust Series 1
|
728.95 | 487.52B | 0 | 0 | 0 | 0.00 |
Amplify Weight Loss Drug Treatment Etf Stock (THNR) Latest News
is medicare going to cover weight loss drugs in 2025 - BusinessWorld Online
From Laggard to Leader: The Surprising Comeback of Healthcare - ETF Trends
what weight loss drug is weight watchers using - BusinessWorld Online
sweeping review suggests effect of weight-loss drugs on 175 conditions - Olhar Digital
glp1 weight loss drug marketplace florida changes 2025 - BusinessWorld Online
new weight loss drug news - Olhar Digital
weight loss drug recently approved by fda - BusinessWorld Online
trump announces weight loss drug - BusinessWorld Online
will medicare cover weight loss drugs in 2026 for seniors - www2.polskieradio.pl
novo nordisk weight loss drug news - polskieradio.pl
Avoiding Lag: Real-Time Signals in (THNR) Movement - Stock Traders Daily
fda approves weight loss drug october 2025 - polskieradio.pl
weight loss drug news today november 24 2025 - Polskie Radio
ETFs with Merck & Co., Inc. ( MRK ) Exposure - etfdb.com
eli lillys new weight loss drug - www.polskieradio.pl
Lilly vs. Novo: Inside the Milan EASD Showdown and the ETFs Poised to Win - The Globe and Mail
Lilly vs. Novo: Inside the Milan EASD Showdown and the ETFs Poised to Win - Zacks Investment Research
Lilly vs. Novo: Inside the Milan EASD Showdown and the ETFs Poised to Win - TradingView
do glp1 pills work as well as injections - polskieradio.pl
the new weight-loss drug - polskieradio.pl
Who Are You Calling Passive? Many Index ETFs Dynamically Rebalanced in September - ETF Database
fda approved weight loss drugs 2026 latest - polskieradio.pl
(THNR) and the Role of Price-Sensitive Allocations - Stock Traders Daily
NTHM’s Index Rebalance Puts Thematic Rotation to Work - ETF Database
5 Best GLP-1 Stocks for 2026 and How to Invest - The Motley Fool
THNR's Weight-Loss Index Swaps Hims & Hers for Gilead - ETF Database
THNR's Weight-Loss Index Swaps Hims & Hers for Gilead - ETF Trends
How (THNR) Movements Inform Risk Allocation Models - Stock Traders Daily
ETFs Investing in Jiangsu Hengrui Pharmaceuticals Co., Ltd. Class H Stocks - TradingView
(THNR) Risk Channels and Responsive Allocation - Stock Traders Daily
CSPC Pharma stock slips as China weight management trial begins - ad-hoc-news.de
(THNR) Price Dynamics and Execution-Aware Positioning - Stock Traders Daily
ETFs Investing in Novo Nordisk A/S Sponsored ADR Class B Stocks - TradingView
Eli Lilly and Co (LLY): The Shop Floor Investor's Journey and Analysis - Moomoo
(THNR) as a Liquidity Pulse for Institutional Tactics - Stock Traders Daily
Pfizer Inc (PFE) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKey
AstraZeneca PLC (AZN) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKey
Scholar Rock Holding Corp (SRRK) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKey
Regeneron Pharmaceuticals Inc (REGN) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKey
Novo Nordisk A/S (NVO) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKey
Hims & Hers Health Inc (HIMS) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKey
Amgen Inc (AMGN) Shareholder Structure: Major Shareholders & Institutional Holdings - tradingkey.com
(THNR) Risk Channels and Responsive Allocation - Stock Traders Daily
ETFs Investing in Novo Nordisk A/S Sponsored ADR Class B Stocks - TradingView
THNR ETF Profile: Dividends, Returns (BOATS:THNR) - TradingView
THNR ETF Profile: Dividends, Returns (AMEX:THNR) - TradingView
(THNR) Risk Channels and Responsive Allocation - Stock Traders Daily
Weight loss drug market to hit $130-150B by 203... - Pluang
Inside THNR: A Leaner Approach to Weight Loss Investing - ETF Database
(THNR) Movement as an Input in Quant Signal Sets - Stock Traders Daily
Amplify Weight Loss Drug Treatment Etf Stock (THNR) Financials Data
There is no financial data for Amplify Weight Loss Drug Treatment Etf (THNR). Check out other stocks for more information.
Revenue
Net Income
Cash Flow
EPS
0.71%
0.04%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):